AGP Executive Report
Last update: 11 hours agoMedical Approvals: Merck’s KEYTRUDA plus Padcev has cleared a positive EU CHMP opinion for cisplatin-ineligible adults with resectable muscle-invasive bladder cancer—neoadjuvant then adjuvant after surgery—now heading to an EU Commission decision expected in Q3 2026. Rare Disease Breakthrough: Pharming’s Joenja (leniolisib) just won EU marketing authorization as the first approved treatment for activated PI3K delta syndrome (APDS), with Germany set for the first launch in Q3 2026. Diplomacy & Culture Clash: A “colonial fantasy” critique swirled around Narendra Modi’s European tour after an Oslo incident reignited questions about how the West views India. Arts & Justice: Uruguay unveiled a major sculpture at ICC headquarters in The Hague, framing it as a symbol of fraternity, diversity, and international justice. Liechtenstein Context: Liechtenstein’s PM told finance leaders that stability is key as global change reshapes the sector. Travel Rules Watch: Thailand cut visa-free stays back to 30 days for most nationalities, tightening entry amid overstays and security concerns.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
